Foqus
Foqus Technologies Inc is a Canadian medical imaging software company that develops DeepFoqus-Accelerate, an FDA-cleared AI and quantum-enhanced MRI reconstruction software that cuts scan times by ~75% for hospitals and imaging centers without requiring hardware upgrades.
- Company typePrivate
- Founded2021
- HeadquartersToronto, Canada
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Foqus does
Foqus Technologies Inc is a Canadian medical imaging software company that develops AI-powered reconstruction software to accelerate MRI scans without requiring hardware modifications to existing 1.5T and 3T scanners. The company's core product, DeepFoqus-Accelerate, reduces MRI acquisition times by approximately 75% (4X acceleration), targeting brain MRI scan durations of under five minutes and supporting 2D and 3D T1, T2, and FLAIR sequences. The company serves hospitals, healthcare systems, and diagnostic imaging centers — segments constrained by long MRI wait times (3-4 months in Canada), patient discomfort during extended scans, and limited scanner throughput.
The technology stack combines proprietary quantum polarization algorithms that boost the physical magnetic resonance signal by nearly 150% (comparable to doubling magnetic field strength without hardware changes) with deep-learning image reconstruction that processes undersampled k-space data into diagnostic-quality output. The IP foundation includes a granted US patent (US10560096B2) covering a quantum signal booster method and pending PCT applications for quantum hyperpolarization and quantum noise suppression. DeepFoqus-Accelerate has been validated on more than 20,000 MRI images and is FDA 510(k) cleared (K241982), Health Canada licensed (113256), and ISO 13485:2016 MDSAP certified.
Foqus generates revenue through software licensing to healthcare providers and MRI service providers, using a direct enterprise sales motion with quote-based pricing. Go-to-market is being built through direct sales in Canada and the United States, a GTM partnership with Mohawk Medbuy Corporation (a national Canadian healthcare procurement organization), and accelerator support from the Boston Canadian Technology Accelerator program for US entry. The company is privately held and backed by venture capital (Quantonation, CABHI), government R&D programs (NRC IRAP, OBIO LSCTC, ISED AI Compute Access Fund, Ontario Brain Institute), and academic support (University of Waterloo). At the time of the source data, Foqus states it is beginning to generate revenue through initial collaborations without disclosing specific revenue figures.
Foqus firmographics
Firmographics- Name
- Foqus
- Legal name
- Foqus Technologies Inc
- Website
- https://foqus.ca
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Foqus Technologies Inc is a Canadian medical imaging software company that develops DeepFoqus-Accelerate, an FDA-cleared AI and quantum-enhanced MRI reconstruction software that cuts scan times by ~75% for hospitals and imaging centers without requiring hardware upgrades.
- Ownership category
- akta.pro rank
Foqus industry classification
Industry- Product category
- Medical Imaging Software
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM)
Keywords
Where Foqus is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Foqus business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Licensing: DeepFoqus-Accelerate is sold as a software solution that integrates with existing MRI scanners. The company generates revenue through software licensing to healthcare providers and MRI service providers. They mention beginning to generate revenue through initial collaborations and planning to achieve profitability.
Distribution channels3 records
Marketing channels6 records
Foqus product offering
Product offeringCore offering
Foqus Technologies develops and sells DeepFoqus-Accelerate, an AI-powered MRI reconstruction software that integrates with existing 1.5T and 3T MRI scanners without requiring hardware modifications. The software uses proprietary quantum algorithms and AI-enhanced reconstruction to accept up to 4x accelerated brain MRI scans (approximately 75% time reduction, with a target of sub-5-minute scans) while maintaining diagnostic-quality image output across 2D and 3D T1, T2, and FLAIR sequences. The product has received FDA 510(k) clearance and Health Canada Medical Device License, enabling commercial deployment to hospitals and imaging centers across North America.
Product overview
Foqus Technologies offers a single core product called DeepFoqus-Accelerate, an AI-powered MRI reconstruction software. This software integrates with existing MRI scanners (no hardware modifications required) and utilizes proprietary AI-enhanced reconstruction algorithms to reduce scan times by 75% while maintaining diagnostic image quality. The technology is backed by two key pillars: Quantum Polarization technology (quantum algorithms boosting signal by 150%) and AI-Accelerated MRI (deep learning image reconstruction). The product has received FDA 510(k) clearance and Health Canada approval, targeting the North American market with a focus on brain MRI imaging.
Differentiator
Problem solved
Functional benefit
Brands
- DeepFoqus-Accelerate: AI-powered MRI reconstruction software for accelerated brain scanning that accepts up to 4x accelerated scans and reconstructs them to yield diagnostic-quality images.
Products and services
- DeepFoqus-Accelerate AI-powered MRI reconstruction software that integrates with existing 1.5T and 3T MRI scanners to accept up to 4x accelerated brain MRI scans and reconstruct diagnostic-quality images, reducing scan times by approximately 75% (with a target of under 5 minutes per scan). It supports 2D T1, 2D T2, 2D FLAIR, 3D T1, 3D T2, and 3D FLAIR sequences and is sold to hospitals, diagnostic imaging centers, and clinical research institutions.
Quantifiable outcome
- 75% reduction in MRI scan time (4X acceleration)
- +4 more outcomes
Companies that use Foqus
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles3 records
Foqus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
Foqus partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Mohawk Medbuy CorporationcoreJoint live webinar on October 15, 2025 showcasing AI-powered MRI innovations. Mohawk Medbuy is a national not-for-profit providing strategic sourcing and procurement solutions for hospitals and healthcare providers across Canada.
- Robarts Research InstitutecoreCompleted a pilot project to validate DeepFoqus-Accelerate performance in real-world clinical settings using 3T MRI systems. The pilot validated software performance and effectiveness, strengthening credibility and driving new collaboration opportunities.
- University of WaterloominorAcademic partner and supporter, with CEO/co-founder Dr. Sadegh Raeisi recognized through Waterloo's entrepreneurship programs.
- Boston Canadian Technology Accelerator (CTA)coreAccelerator program supporting high-potential companies in Tech and Life Sciences sectors with mentoring, local ecosystem connections, and opportunities to grow in the US market.
Scale indicators6 records
Recent moves6 records
Expansion highlights3 records
Foqus competitors and assessment
Company assessmentDirect peers
- Quibim: Quibim provides AI-based medical image analysis and quantification, with MRI-focused products for radiology and research customers; comparable AI-imaging value proposition and customer base.
- SyntheticMR: SyntheticMR offers SyMRI software for quantitative MRI and faster brain scans via synthetic imaging, overlapping with Foqus's brain MRI acceleration focus and hospital radiology workflow.
- RapidAI: RapidAI provides AI-driven imaging analysis (mainly stroke and neurovascular), serving hospital radiology and stroke networks; comparable AI imaging workflow footprint to Foqus in neuro MRI.
- Subtle Medical: Subtle Medical builds AI-powered MRI and PET acceleration software (SubtleMR, SubtleGAD) that integrates with existing scanners. Direct overlap with DeepFoqus-Accelerate in AI reconstruction and hospital sales motion.
- Arterys (Tempus): Arterys (now part of Tempus AI) provides cloud-native AI medical imaging platforms including MRI quantification and visualization, competing for AI imaging analytics budgets at the same hospital radiology departments.
Broad incumbents
- GE HealthCare: GE HealthCare is a major MRI OEM whose AIR Recon DL product is an AI-based MRI reconstruction tool bundled with its scanners. Represents both a competing AI reconstruction solution and a potential integration channel for Foqus.
- Siemens Healthineers: Siemens Healthineers offers Deep Resolve, an AI-based MRI acceleration technology integrated into its MAGNETOM scanners, making it a direct competing AI reconstruction capability and a key OEM counterpart.
- Philips: Philips offers SmartSpeed AI MRI acceleration as part of its Ingenia and other MR platforms, providing competing vendor-bundled reconstruction and a major OEM integration target for Foqus.
Emerging players
- Ezra: Ezra offers AI-assisted full-body MRI screening with a focus on faster, more accessible scans for early cancer detection; overlaps with Foqus on the AI-driven faster-MRI thesis but targets consumers/employers.
- Hyperfine: Hyperfine develops portable, low-field MRI with AI-driven reconstruction, targeting point-of-care and lower-cost settings; adjacent technology (AI + MRI acceleration) and overlapping MRI access mission.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Foqus social profiles
Digital presenceFoqus compliance and trust
Trust signalCompliance4 records
Foqus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Foqus leadership team
Management profileNumber of profiles
Profiles1 record
Foqus funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Foqus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Foqus
What does Foqus do?
Foqus Technologies develops and sells DeepFoqus-Accelerate, an AI-powered MRI reconstruction software that integrates with existing 1.5T and 3T MRI scanners without requiring hardware modifications. The software uses proprietary quantum algorithms and AI-enhanced reconstruction to accept up to 4x accelerated brain MRI scans (approximately 75% time reduction, with a target of sub-5-minute scans) while maintaining diagnostic-quality image output across 2D and 3D T1, T2, and FLAIR sequences. The product has received FDA 510(k) clearance and Health Canada Medical Device License, enabling commercial deployment to hospitals and imaging centers across North America.
Is Foqus a public or private company?
Foqus is a private company. It is classified as venture growth investor backed and is currently operating.
When was Foqus founded?
Foqus was founded in 2021. It employs 11 to 50 people.
Where is Foqus based?
Foqus is headquartered in Toronto, Canada, in the North America region.
How does Foqus make money?
One revenue line is on record: software Licensing.
Who are Foqus's main competitors?
Direct peers on record are Quibim, SyntheticMR, RapidAI, Subtle Medical and Arterys (Tempus). Broad incumbents are GE HealthCare, Siemens Healthineers and Philips. Emerging players are Ezra and Hyperfine.
Does Foqus have an API?
No public API is recorded for Foqus.
What industry is Foqus in?
Foqus's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 3391 and its SIC code is 3841.